These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 37988664)
1. Germline PRKACA amplification-associated primary pigmented nodular adrenocortical disease: a case report and literature review. Yang WR; Liang XH; Qin YF; Yang HY; He SZ; Huang ZX; Liu YP; Luo ZJ Arch Endocrinol Metab; 2023 Nov; 68():e220491. PubMed ID: 37988664 [TBL] [Abstract][Full Text] [Related]
2. [A girl with Cushing's syndrome due to primary pigmented nodular adrenocortical disease]. Bocca G; van Mil EG; Voorhoeve PG; Wijnaendts LC; Delemarre-van de Waal HA Ned Tijdschr Geneeskd; 2006 Oct; 150(43):2390-3. PubMed ID: 17100132 [TBL] [Abstract][Full Text] [Related]
3. The clinical characteristics and pathogenic variants of primary pigmented nodular adrenocortical disease in 210 patients: a systematic review. Sun J; Ding L; He L; Fu H; Li R; Feng J; Dong J; Liao L Front Endocrinol (Lausanne); 2024; 15():1356870. PubMed ID: 39006359 [TBL] [Abstract][Full Text] [Related]
4. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893 [TBL] [Abstract][Full Text] [Related]
5. Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations. Lodish MB; Yuan B; Levy I; Braunstein GD; Lyssikatos C; Salpea P; Szarek E; Karageorgiadis AS; Belyavskaya E; Raygada M; Faucz FR; Izzat L; Brain C; Gardner J; Quezado M; Carney JA; Lupski JR; Stratakis CA Eur J Endocrinol; 2015 Jun; 172(6):803-11. PubMed ID: 25924874 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent Cushing syndrome. Chen S; Li R; Lu L; Duan L; Zhang X; Tong A; Pan H; Zhu H; Lu Z Endocrine; 2018 Jan; 59(1):183-190. PubMed ID: 29094256 [TBL] [Abstract][Full Text] [Related]
11. Carney Complex Complicated with Primary Pigmented Nodular Adrenocortical Disease without Cushing's Syndrome Recurrence for Five Years after Unilateral Adrenalectomy. Tsurutani Y; Kiriyama K; Kondo M; Hasebe M; Sata A; Mizuno Y; Sugisawa C; Saito J; Nishikawa T Intern Med; 2022; 61(2):205-211. PubMed ID: 35034934 [TBL] [Abstract][Full Text] [Related]
13. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689 [TBL] [Abstract][Full Text] [Related]
14. Primary pigmented nodular adrenocortical disease: reevaluation of a patient with carney complex 27 years after unilateral adrenalectomy. Sarlis NJ; Chrousos GP; Doppman JL; Carney JA; Stratakis CA J Clin Endocrinol Metab; 1997 Apr; 82(4):1274-8. PubMed ID: 9100606 [TBL] [Abstract][Full Text] [Related]
15. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? Gunther DF; Bourdeau I; Matyakhina L; Cassarino D; Kleiner DE; Griffin K; Courkoutsakis N; Abu-Asab M; Tsokos M; Keil M; Carney JA; Stratakis CA J Clin Endocrinol Metab; 2004 Jul; 89(7):3173-82. PubMed ID: 15240590 [TBL] [Abstract][Full Text] [Related]
16. An unusual presentation of Carney complex with diffuse primary pigmented nodular adrenocortical disease on one adrenal gland and a nonpigmented adrenocortical adenoma and focal primary pigmented nodular adrenocortical disease on the other. Tung SC; Hwang DY; Yang JW; Chen WJ; Lee CT Endocr J; 2012; 59(9):823-30. PubMed ID: 22785148 [TBL] [Abstract][Full Text] [Related]